Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer
Clinical trial NCT01326481 · COMPLETED
Trial details
- NCT number
- NCT01326481
- Sponsor
- Tracon Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2014-09-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.